Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology, will swallow Chicago-area biopharmaceutical developer NeoPharm Inc. (OTC:NEOL.PK) through a reverse merger ...

In a blow to the Chicago area’s emerging biotechnology industry, a Waukegan-based firm faced doubt about its future Monday after disclosing that its experimental brain-tumor-shrinking drug did not ...

A Lake Forest-based biotech company Thursday said it terminated a licensing agreement with the world’s largest drug company, ending a pact to develop cancer drugs. NeoPharm Inc. said the rights to ...

MONTREAL, QC and BOSTON, MA--(Marketwired - Nov 3, 2016) - Neopharm Labs Inc., a leading Quebec-based full-service pharmaceutical testing laboratory, announces its expansion into the United States ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. As Guillermo Herrera wrapped up his first conference call ...

There's an exclusive group of companies in the stock market that stand out because they've got what billionaire investor Warren Buffett calls economic moats. Like medieval castles, their profits are ...

NeoPharm Inc.'s stock perked up on encouraging test results for its brain cancer drug. Shares of the Lake Forest-based biotech company closed at $11.25 Friday, up 44% in the two weeks since the firm's ...

SYDNEY, AUSTRALIA--(Marketwired - Nov 6, 2013) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN:US74154B2034) ("Prima", the "Company") is pleased to announce that it has entered into a binding term ...

WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (NASDAQ:NEOL), today announced that it has entered into an exclusive patent license agreement with the National Institutes of Health (NIH) for the ...

LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (Other OTC: NEOL.PK), a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic ...